The Net Margin of Provectus Biopharmaceuticals Inc (PVCT) is -766.85%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -766.85% |
2023-12-31 | -556.16% |
2022-12-31 | -358.59% |